188 related articles for article (PubMed ID: 16002527)
1. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and overactivation of Akt in thyroid carcinoma.
Ringel MD; Hayre N; Saito J; Saunier B; Schuppert F; Burch H; Bernet V; Burman KD; Kohn LD; Saji M
Cancer Res; 2001 Aug; 61(16):6105-11. PubMed ID: 11507060
[TBL] [Abstract][Full Text] [Related]
4. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
5. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
Furuya F; Hanover JA; Cheng SY
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
[TBL] [Abstract][Full Text] [Related]
6. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
7. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
[TBL] [Abstract][Full Text] [Related]
8. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
9. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
Kato Y; Ying H; Willingham MC; Cheng SY
Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY
Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624
[TBL] [Abstract][Full Text] [Related]
12. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
Suzuki H; Willingham MC; Cheng SY
Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
[TBL] [Abstract][Full Text] [Related]
13. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.
Vasko V; Saji M; Hardy E; Kruhlak M; Larin A; Savchenko V; Miyakawa M; Isozaki O; Murakami H; Tsushima T; Burman KD; De Micco C; Ringel MD
J Med Genet; 2004 Mar; 41(3):161-70. PubMed ID: 14985374
[TBL] [Abstract][Full Text] [Related]
14. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
15. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
Miao X; Zhao Y
Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
[TBL] [Abstract][Full Text] [Related]
16. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
[TBL] [Abstract][Full Text] [Related]
17. Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer.
Saji M; Narahara K; McCarty SK; Vasko VV; La Perle KM; Porter K; Jarjoura D; Lu C; Cheng SY; Ringel MD
Oncogene; 2011 Oct; 30(42):4307-15. PubMed ID: 21532616
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
Guigon CJ; Fozzatti L; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2010 Jul; 31(7):1284-91. PubMed ID: 20299527
[TBL] [Abstract][Full Text] [Related]
19. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
Amornphimoltham P; Sriuranpong V; Patel V; Benavides F; Conti CJ; Sauk J; Sausville EA; Molinolo AA; Gutkind JS
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4029-37. PubMed ID: 15217935
[TBL] [Abstract][Full Text] [Related]
20. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
Furuya F; Lu C; Guigon CJ; Cheng SY
Steroids; 2009 Jul; 74(7):628-34. PubMed ID: 19014961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
